Epidermal growth factor receptor signalling mediates growth hormone-induced growth of chondrocytes from sex hormone-inhibited adolescent rats

Clinical and Experimental Pharmacology and Physiology

Volumn 38, Issue 8, 2011, Pages 534-542

  Pan, Si Nian ^a,b   Ma, Hua Mei ^a   Su, Zhe ^a   Zhang, Cheng Xi ^b   Zhu, Shen Ye ^b   Du, Min Lian ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Central precocious puberty; Epidermal growth factor receptor; Epiphyseal growth plate; Gonadotropin releasing hormone analogue; Growth hormone

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; GONADORELIN; GROWTH HORMONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; NEUTRALIZING ANTIBODY; RECOMBINANT GROWTH HORMONE; SEX HORMONE;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROWTH PLATE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INHIBITION KINETICS; NONHUMAN; PRECOCIOUS PUBERTY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; AUTOCRINE COMMUNICATION; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GONADAL STEROID HORMONES; GROWTH PLATE; HUMAN GROWTH HORMONE; JANUS KINASE 2; PROLIFERATING CELL NUCLEAR ANTIGEN; PUBERTY, PRECOCIOUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 79960727298     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2011.05547.x     Document Type: Article

References (40)

1. Merke DP, Cutler GB Jr. Evaluation and management of precocious puberty. Arch. Dis. Child. 1996; 75: 269-71.
2. Nebesio TD, Eugster EA. Current concepts in normal and abnormal puberty. Curr. Probl. Pediatr. Adolesc. Health Care 2007; 37: 50-72.
3. Partsch CJ, Heger S, Sippell WG. Management and outcome of central precocious puberty. Clin. Endocrinol. 2002; 56: 129-48.
4. Wilson AC, Meethal SV, Bowen RL, Atwood CS. Leuprolide acetate: A drug of diverse clinical applications. Expert Opin. Invest. Drugs 2007; 16: 1851-63.
5. Franchimont P, Bassleer C, Henrotin Y. Effects of hormones and drugs on cartilage repair. J. Rheumatol. Suppl. 1989; 18: 5-9.
6. Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method. Horm. Res. 1997; 47: 54-61.
7. Oerter KE, Manasco PK, Barnes KM, Jones J, Hill S, Cutler GB Jr. Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-releasing hormone-dependent precocious puberty. Acta Paediatr. Suppl. 1993; 388: 62-8.
8. Oostdijk W, Rikken B, Schreuder S et al. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch. Dis. Child. 1996; 75: 292-7.
9. Pasquino AM, Municchi G, Pucarelli I, Segni M, Mancini MA, Troiani S. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty. J. Clin. Endocrinol. Metab. 1996; 81: 948-51.
10. Sklar CA, Rothenberg S, Blumberg D, Oberfield SE, Levine LS, David R. Suppression of the pituitary-gonadal axis in children with central precocious puberty: Effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion. J. Clin. Endocrinol. Metab. 1991; 73: 734-8.
11. Kamp GA, Manasco PK, Barnes KM et al. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty. J. Clin. Endocrinol. Metab. 1991; 72: 301-7.
12. Tato L, Saggese G, Cavallo L et al. Use of combined Gn-RH agonist and hGH therapy for better attining the goals in precocious puberty treatment. Horm. Res. 1995; 44 (Suppl. 3): 49-54.
13. Juul A, Fisker S, Scheike T et al. Serum levels of growth hormone binding protein in children with normal and precocious puberty: Relation to age, gender, body composition and gonadal steroids. Clin. Endocrinol. 2000; 52: 165-72.
14. Juul A, Scheike T, Nielsen CT, Krabbe S, Muller J, Skakkebaek NE. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: Effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate). J. Clin. Endocrinol. Metab. 1995; 80: 3059-67.
15. Saggese G, Pasquino AM, Bertelloni S et al. Effect of combined treatment with gonadotropin releasing hormone analogue and growth hormone in patients with central precocious puberty who had subnormal growth velocity and impaired height prognosis. Acta Paediatr. 1995; 84: 299-304.
16. Juul A, Flyvbjerg A, Frystyk J, Muller J, Skakkebaek NE. Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins-1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty. Clin. Endocrinol. 1996; 44: 515-23.
17. Muller J, Juul A, Andersson AM, Sehested A, Skakkebaek NE. Hormonal changes during GnRH analogue therapy in children with central precocious puberty. J. Pediatr. Endocrinol. Metab. 2000; 13 (Suppl. 1): 739-46.
18. Cisternino M, Draghi M, Lauriola S et al. The acid-labile subunit of human ternary insulin-like growth factor-binding protein complex in girls with central precocious puberty before and during gonadotropin-releasing hormone analog therapy. J. Clin. Endocrinol. Metab. 2002; 87: 4629-33.
19. van der Eerden BC, Karperien M, Wit JM. Systemic and local regulation of the growth plate. Endocr. Rev. 2003; 24: 782-801.
20. Spagnoli A, Rosenfeld RG. The mechanisms by which growth hormone brings about growth. The relative contributions of growth hormone and insulin-like growth factors. Endocrinol. Metab. Clin. North Am. 1996; 25: 615-31.
21. Yamauchi T, Ueki K, Tobe K et al. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature 1997; 390: 91-6.
22. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW. Epidermal growth factor receptor: Mechanisms of activation and signalling. Exp. Cell Res. 2003; 284: 31-53.
23. Xian CJ. Roles of epidermal growth factor family in the regulation of postnatal somatic growth. Endocr. Rev. 2007; 28: 284-96.
24. Tajima Y, Kato K, Kashimata M, Hiramatsu M, Utsumi N. Immunohistochemical analysis of EGF in epiphyseal growth plate from normal, hypophysectomized, and growth hormone-treated hypophysectomized rats. Cell Tissue Res. 1994; 278: 279-82.
25. Chan SY, Wong RW. Expression of epidermal growth factor in transgenic mice causes growth retardation. J. Biol. Chem. 2000; 275: 38693-8.
26. Miettinen PJ, Berger JE, Meneses J et al. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 1995; 376: 337-41.
27. Threadgill DW, Dlugosz AA, Hansen LA et al. Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype. Science 1995; 269: 230-4.
28. Sibilia M, Steinbach JP, Stingl L, Aguzzi A, Wagner EF. A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor. EMBO J. 1998; 17: 719-31.
29. Halevy O, Schindler D, Hurwitz S, Pines M. Epidermal growth factor receptor gene expression in avian epiphyseal growth-plate cartilage cells: Effect of serum, parathyroid hormone and atrial natriuretic peptide. Mol. Cell. Endocrinol. 1991; 75: 229-35.
30. Monsonego E, Halevy O, Gertler A, Hurwitz S, Pines M. Growth hormone inhibits differentiation of avian epiphyseal growth-plate chondrocytes. Mol. Cell. Endocrinol. 1995; 114: 35-42.
31. Bonassar LJ, Trippel SB. Interaction of epidermal growth factor and insulin-like growth factor-I in the regulation of growth plate chondrocytes. Exp. Cell Res. 1997; 234: 1-6.
32. Zhu SY, Li YH, Ma HM, Pan SN, Chen HS, Du ML. Stanozolol activates the cross-talk of estrogen receptor alpha-insulin-like growth factor-1 receptor-extracellular-signal regulated kinase 1/2 in the growth plate chondrocytes of estrogen-inhibited adolescent rats in vitro. Zhonghua Er Ke Za Zhi 2009; 47: 774-8.
33. Institute of Laboratory Animal Research, Commission on Life Sciences, National Research Council. Guide for the Care and Use of Laboratory Animals. National Academies Press, Washington, DC. 1996.
34. Huang Q, Cheung AP, Zhang Y, Huang HF, Auersperg N, Leung PC. Effects of growth differentiation factor 9 on cell cycle regulators and ERK42/44 in human granulosa cell proliferation. Am. J. Physiol. Endocrinol. Metab. 2009; 296: E1344-53.
35. Swartz CD, Afshari CA, Yu L, Hall KE, Dixon D. Estrogen-induced changes in IGF-1, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines. Mol. Hum. Reprod. 2005; 11: 441-50.
36. Huang Y, Kim SO, Jiang J, Frank SJ. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. J. Biol. Chem. 2003; 278: 18902-13.
37. Gu Y, Zou Y, Aikawa R et al. Growth hormone signalling and apoptosis in neonatal rat cardiomyocytes. Mol. Cell. Biochem. 2001; 223: 35-46.
38. Yuan G, Gu Y. Epidermal growth factor receptor participates in growth hormone signaling pathway in cardiac myocytes of neonatal rat. Chin. Med. J. 1999; 112: 546-9.
39. Rodland KD, Bollinger N, Ippolito D et al. Multiple mechanisms are responsible for transactivation of the epidermal growth factor receptor in mammary epithelial cells. J. Biol. Chem. 2008; 283: 31477-87.
40. Rogers SA, Rasmussen J, Miller SB, Hammerman MR. Effects of growth hormone on rat renal epidermal growth factor expression. Am. J. Physiol. 1994; 267: F208-14.